MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Prognostic significance of peripheral neutrophils and lymphocytes in early Parkinson’s disease

    JS. Jun, R. Kim (Seoul, Republic of Korea)

    Objective: To explore whether peripheral blood neutrophils and lymphocytes are associated with longitudinal motor and cognitive decline in patients with early Parkinson’s disease (PD) and,…
  • 2023 International Congress

    Benefits of Physician-Pharmacist Collaboration on Patient Outcomes in Parkinson’s Disease and Movement Disorders Clinic

    P. Techa-Angkoon, Y. Pitakpatapee, W. Saengphatrachai, P. Srivanitchapoom, T. Suansanae (Bangkok, Thailand)

    Objective: To evaluate the impact of pharmacist participation in Parkinson’s disease and movement disorders clinic on the number of drug-related problems (DRPs), clinical outcomes, and…
  • 2023 International Congress

    Hypothalamic involvement in Multiple System Atrophy: a clinical and neuroimaging study

    J. Pasquini, M. Firbank, L. Best, V. Foster, R. Ceravolo, G. Petrides, K. Anderson, D. Brooks, N. Pavese (Pisa, Italy)

    Objective: To investigate hypothalamic atrophy and its clinical correlates in Multiple System Atrophy (MSA) through MRI. Background: MSA is characterized by autonomic dysfunction, i.e. orthostatic…
  • 2023 International Congress

    Pallidal DBS improves myoclonus in 2 patients with post-hypoxic myoclonus

    L. Pan, A. Mogilner, S. Frucht (New York, USA)

    Objective: Describe DBS for 2 patients with severe post-hypoxic myoclonus. Background: Limited prior reports have shown improvement of PHM after DBS. We describe 2 recent…
  • 2023 International Congress

    Hypnosis as an adjunctive treatment for FND, a case series

    J. Chen, J. Waugh, K. Brewer-Mixon, S. Chitnis, D. Morris (Dallas, USA)

    Objective: To review three cases of Functional Neurologic Disorder (FND) that resolved successfully with Hypnosis and to identify the specific techniques and reasons behind their…
  • 2023 International Congress

    Understanding Social Isolation before, during and after the Covid-19 pandemic among Patients with Parkinson’s disease

    A. Mehta, S. Ng, N. Chia, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan (Singapore, Singapore)

    Objective: The aim of this study was to understand and measure the effect of social network support in patients with Parkinson’s disease(PwP) before, during and…
  • 2023 International Congress

    Establishing a Natural History of X-linked Dystonia Parkinsonism

    P. Acuna, ML. Supnet-Wells, N. Spencer, JK. de Guzman, M. Russo, A. Hunt, C. Stephen, C. Go, S. Carr, N. Ganza-Bautista, JB. Lagarde, S. Begalan, T. Muthaupt-Buell, G. Aldykiewicz, L. Paul, L. Ozelius, C. Bragg, B. Perry, J. Green, J. Miller, N. Sharma (Roxas City, Philippines)

    Objective: Our main objective is to establish a comprehensive, quantitative assessment of movement dysfunction and bulbar motor impairments that are sensitive and specific to disease…
  • 2023 International Congress

    The Value of Physician Assistant/Associates (PAs) in a Movement Disorder Clinic

    J. Karl, C. Cooper (Chicago, USA)

    Objective: To assess the value and productivity of physician assistants/associates (PA) in a movement disorder clinic. Background: Due to the aging population and shortage of…
  • 2023 International Congress

    Validation and replication of Parkinson disease behavioral subtypes

    C. Lessov-Schlaggar, P. Myers, J. Jackson, B. Maiti, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To validate and replicate clinical subtypes of Parkinson disease. Background: We recently identified three distinct clinical subtypes of Parkinson disease: motor (predominant motor with…
  • 2023 International Congress

    Effort-based decision-making and neuropsychiatric symptoms before and after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    D. Amstutz, M. Sousa, K. Petermann, A. Botros, M. Maradan-Gachet, I. Debove, L. Lachenmayer, A. Diamantaras, J. Waskönig, C. Pollo, D. Cazzoli, T. Nef, M. Husain, P. Krack (Bern, Switzerland)

    Objective: Parkinson’s disease patients with apathy and patients in the medication OFF state show reduced reward sensitivity in effort-based decision-making tasks. The effect of subthalamic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley